Increased Interleukin-10 Production Without Expansion of CD4+CD25+ T-Regulatory Cells in Early Stable Renal Transplant Patients on Calcineurin Inhibitors-Reference-Cited by-同舟云学术

Increased Interleukin-10 Production Without Expansion of CD4+CD25+ T-Regulatory Cells in Early Stable Renal Transplant Patients on Calcineurin Inhibitors

Published:2009-08-15 Issue:3 Volume:88 Page:435-441
ISSN:0041-1337
Container-title:Transplantation
language:en
Short-container-title:

Author:

Mittal Sharad K.,Sharma Raj Kumar,Gupta Amit,Naik Sita

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Transplantation

Reference38 articles.

1. The aetiology and pathogenesis of chronic allograft nephropathy.;Yates;Transpl Immunol,2006

2. Preventing renal transplant failure.;Vathsala;Ann Acad Med Singapore,2005

3. Modifications of the conditioning regimen for achieving mixed chimerism and donor-specific tolerance in cynomolgus monkeys.;Kimikawa;Transplantation,1997

4. Naturally arising Foxp3-expressing CD25+CD4+ regulatory T cells in immunological tolerance to self and non-self.;Sakaguchi;Nat Immunol,2005

5. A well adapted regulatory contrivance: Regulatory T cell development and the forkhead family transcription factor Foxp3.;Fontenot;Nat Immunol,2005

Cited by 26 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. TIPE2 deficiency prolongs mouse heart allograft survival by facilitating immature DCs-induced Treg generation;Clinical Immunology;2023-07

2. CD4+CD25+ T regulatory cells in renal transplantation;Frontiers in Immunology;2022-11-08

3. Effect of regulatory T cells on short-term graft outcome in kidney transplant recipients, a prospective observational, single-center study;Transplant Immunology;2022-08

4. Capacity of Retinal Ganglion Cells Derived from Human Induced Pluripotent Stem Cells to Suppress T-Cells;International Journal of Molecular Sciences;2020-10-22

5. Enzyme-Linked Immunosorbent Spot (ELISpot) monitoring of cytokine-producing cells for the prediction of acute rejection in renal transplant patients;European Cytokine Network;2017-09